Articles

Toward optimizing the use of deferasirox: potential benefits of combined use with deferoxamine

Division of Pediatric Hematology/Oncology, New York Presbyterian Hospital, New York, NY, USA
Clinica Pediatrica 2a, Dipartimento di Scienze Biomediche e Biotecnologie, Università di Cagliari, Ospedale Regionale Microtemie ASL8, Cagliari, Italy
Division of Pediatric Hematology/Oncology, New York Presbyterian Hospital, New York, NY, USA
Division of Pediatric Hematology/Oncology, New York Presbyterian Hospital, New York, NY, USA
Clinica Pediatrica 2a, Dipartimento di Scienze Biomediche e Biotecnologie, Università di Cagliari, Ospedale Regionale Microtemie ASL8, Cagliari, Italy
Division of Pediatric Hematology/Oncology, New York Presbyterian Hospital, New York, NY, USA
Vol. 98 No. 1 (2013): January, 2013 https://doi.org/10.3324/haematol.2012.070607